Literature DB >> 19932134

Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome.

Regina Dahlhaus1, Alaa El-Husseini.   

Abstract

The fragile X syndrome (FXS) is the most common form of inherited mental retardation. Caused by a transcriptional silencing of the fragile X mental retardation protein (FMRP), a mRNA binding protein itself, misregulated translation is thought to be the leading cause of the fragile X syndrome. Interestingly, recent results indicated several neuroligin interacting proteins to be affected by this misregulation, including neurexin1 and PSD95, which have also been implicated in autism spectrum disorders. Using co-immunoprecipitation assays and RT-PCR, FMRP is shown to interact with neuroligin1- and 2-mRNA, while no interaction with neuroligin3-mRNA is observed. In line with FMRP's role in translation regulation, Western blot as well as immunohistochemistry analysis reveal changes in protein expression levels suggesting impaired synaptic function. As increasing evidence indicates neuroligin expression to be critical for synapse maturation and function, consequences of impaired neuroligin1 expression in FXS are assessed by overexpressing HA-neuroligin1 in FMR1-/- mice, a model for FXS. Behavioural assessments demonstrate that enhanced neuroligin1 expression improves social behaviour in FMR1-/- mice, whereas no positive effect on learning and memory is seen. These results provide for the first time evidence for an involvement of a neuroligin-neurexin protein network in core symptoms of FXS. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932134     DOI: 10.1016/j.bbr.2009.11.019

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  50 in total

Review 1.  Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.

Authors:  E Carla Parker-Athill; Jun Tan
Journal:  Neurosignals       Date:  2010-10-02

Review 2.  Fragile X syndrome: the GABAergic system and circuit dysfunction.

Authors:  Scott M Paluszkiewicz; Brandon S Martin; Molly M Huntsman
Journal:  Dev Neurosci       Date:  2011-09-21       Impact factor: 2.984

Review 3.  Moving Toward Integrative, Multidimensional Research in Modern Psychiatry: Lessons Learned From Fragile X Syndrome.

Authors:  Lawrence K Fung; Allan L Reiss
Journal:  Biol Psychiatry       Date:  2015-12-18       Impact factor: 13.382

Review 4.  Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders.

Authors:  Greg C Carlson
Journal:  Pharmacol Biochem Behav       Date:  2011-02-16       Impact factor: 3.533

5.  Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2.

Authors:  Markus Wöhr; Jill L Silverman; Maria L Scattoni; Sarah M Turner; Mark J Harris; Roheeni Saxena; Jacqueline N Crawley
Journal:  Behav Brain Res       Date:  2012-07-20       Impact factor: 3.332

6.  CaMKII phosphorylation of neuroligin-1 regulates excitatory synapses.

Authors:  Michael A Bemben; Seth L Shipman; Takaaki Hirai; Bruce E Herring; Yan Li; John D Badger; Roger A Nicoll; Jeffrey S Diamond; Katherine W Roche
Journal:  Nat Neurosci       Date:  2013-12-15       Impact factor: 24.884

Review 7.  The molecular basis of cognitive deficits in pervasive developmental disorders.

Authors:  Aditi Bhattacharya; Eric Klann
Journal:  Learn Mem       Date:  2012-08-16       Impact factor: 2.460

8.  Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.

Authors:  Randi Hagerman; Gry Hoem; Paul Hagerman
Journal:  Mol Autism       Date:  2010-09-21       Impact factor: 7.509

9.  Neuroligin1 drives synaptic and behavioral maturation through intracellular interactions.

Authors:  Jennifer L Hoy; Paola A Haeger; John R L Constable; Renee J Arias; Raluca McCallum; Michael Kyweriga; Lawrence Davis; Eric Schnell; Michael Wehr; Pablo E Castillo; Philip Washbourne
Journal:  J Neurosci       Date:  2013-05-29       Impact factor: 6.167

Review 10.  Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links.

Authors:  S W Hulbert; Y-H Jiang
Journal:  Neuroscience       Date:  2015-12-28       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.